Viewing Study NCT01933958


Ignite Creation Date: 2025-12-25 @ 12:21 AM
Ignite Modification Date: 2025-12-25 @ 10:25 PM
Study NCT ID: NCT01933958
Status: COMPLETED
Last Update Posted: 2022-04-01
First Post: 2013-08-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Regorafenib Post-marketing Surveillance in Japan
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastrointestinal Stromal Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Regorafenib View
None Gastrointestinal stromal tumors View